Literature DB >> 27040822

Expression of a Chimeric Allergen with High Rare Codons Content in Codon Bias-Adjusted Escherichia coli: Escherichia coli BL21 (DE3)-Codon Plus RIL as an Efficient Host.

Hamid Reza Nouri1, Ahmad Karkhah2, Abdolreza Varasteh3, Mojtaba Sankian4.   

Abstract

The expression of heterologous proteins in Escherichia coli (E. coli) is importantly affected by codon bias. Hence, the aim of the current study was to determine which codon bias-adjusted E. coli strain is sufficient for expression of a chimeric allergen coded by high rare codon content. To investigate the expression level, a chimeric protein of Chenopodium album (C. album) was used as an appropriate model. An expression construct was assembled and was transformed to four strains of codon bias-adjusted E. coli including origami, BL21 (DE3), BL21 (DE3)-codon plus RIL, and Rosetta. The level of expression and solubility of the chimeric allergen was analyzed by SDS-PAGE. In addition, the allergenicity of chimeric allergen was determined using immunoblotting. Our results showed that the chimeric allergen was expressed at high level in E. coli BL21 (DE3)-codon plus RIL and Rosetta. In detail, this recombinant allergen was isolated from soluble fraction in the codon bias-adjusted strains of E. coli BL21 (DE3)-codon plus RIL and Rosetta. Moreover, some lower molecular weight proteins were observed in Rosetta, which could be related to inappropriate expression or broken compartments of the chimeric allergen. The immunoblotting assay confirmed that the IgE-specific immune reactivity of our chimeric allergen expressed in BL21 (DE3)-codon plus RIL was significantly higher than the other strains. Our results showed that the expression of the chimeric allergen with high rare codons content in a codon bias-adjusted strain E. coli BL21 (DE3)-codon plus RIL improves the quality and solubility of the heterologous protein production.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27040822     DOI: 10.1007/s00284-016-1027-7

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


  23 in total

1.  A novel phospholipase A2/esterase from hyperthermophilic archaeon Aeropyrum pernix K1.

Authors:  Baijing Wang; Dongmei Lu; Renjun Gao; Zhen Yang; Shugui Cao; Yan Feng
Journal:  Protein Expr Purif       Date:  2004-06       Impact factor: 1.650

Review 2.  Production of active eukaryotic proteins through bacterial expression systems: a review of the existing biotechnology strategies.

Authors:  Sudhir Sahdev; Sunil K Khattar; Kulvinder Singh Saini
Journal:  Mol Cell Biochem       Date:  2007-09-12       Impact factor: 3.396

3.  Engineering Escherichia coli for functional expression of membrane proteins.

Authors:  Franz Y Ho; Bert Poolman
Journal:  Methods Enzymol       Date:  2015-03-20       Impact factor: 1.600

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Understanding the relationship between the primary structure of proteins and its propensity to be soluble on overexpression in Escherichia coli.

Authors:  Susan Idicula-Thomas; Petety V Balaji
Journal:  Protein Sci       Date:  2005-02-02       Impact factor: 6.725

Review 6.  Advanced genetic strategies for recombinant protein expression in Escherichia coli.

Authors:  Hans Peter Sørensen; Kim Kusk Mortensen
Journal:  J Biotechnol       Date:  2005-01-26       Impact factor: 3.307

7.  Development of new IgE specificities to allergenic components in birch pollen extract during specific immunotherapy studied with immunoblotting and Pharmacia CAP System.

Authors:  Robert Movérare; L Elfman; E Vesterinen; T Metso; T Haahtela
Journal:  Allergy       Date:  2002-05       Impact factor: 13.146

8.  Recombinant expression, purification and cross-reactivity of chenopod profilin: rChe a 2 as a good marker for profilin sensitization.

Authors:  Rodrigo Barderas; Mayte Villalba; Rosalía Rodríguez
Journal:  Biol Chem       Date:  2004-08       Impact factor: 3.915

9.  Vaccination with genetically engineered allergens prevents progression of allergic disease.

Authors:  V Niederberger; F Horak; S Vrtala; S Spitzauer; M-T Krauth; P Valent; J Reisinger; M Pelzmann; B Hayek; M Kronqvist; G Gafvelin; H Grönlund; A Purohit; R Suck; H Fiebig; O Cromwell; G Pauli; M van Hage-Hamsten; R Valenta
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-13       Impact factor: 11.205

10.  Optimizing HIV-1 protease production in Escherichia coli as fusion protein.

Authors:  Federica Volontè; Luciano Piubelli; Loredano Pollegioni
Journal:  Microb Cell Fact       Date:  2011-06-30       Impact factor: 5.328

View more
  3 in total

Review 1.  Overcoming the Solubility Problem in E. coli: Available Approaches for Recombinant Protein Production.

Authors:  Claudia Ortega; Pablo Oppezzo; Agustín Correa
Journal:  Methods Mol Biol       Date:  2022

Review 2.  Current trends in biopharmaceuticals production in Escherichia coli.

Authors:  L McElwain; K Phair; C Kealey; D Brady
Journal:  Biotechnol Lett       Date:  2022-07-07       Impact factor: 2.716

3.  Expression and immunoreactivity of a recombinant multi-epitope antigen designed based on four major structural proteins of avian infectious bronchitis virus.

Authors:  Qing Liu; Jin Li; Run-Li Li; Ye-Ting Ma; Peng-Lai Zhou; Wen-Wei Gao; Hai-Li Ma
Journal:  3 Biotech       Date:  2020-02-04       Impact factor: 2.406

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.